Immunosuppression in infants with short bowel syndrome undergoing isolated liver transplantation

Pediatric Transplantation

Volumn 10, Issue 6, 2006, Pages 677-681

  Olio, Dominic Dell ^a   Gupte, Girish ^a   Sharif, Khalid ^a   Murphy, M S ^b   Lloyd, Carla ^a   McKiernan, Patrick J ^a   Kelly, Deirdre A ^a   Beath, Susan V ^c  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b Department of Paediatric Gastroenterology   (United Kingdom)

^c Birmingham Children's Hospital ^*

Author keywords

Acute rejection; Immunosuppression; Intestinal failure associated liver disease; Liver transplant; Short bowel syndrome

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

AGE DISTRIBUTION; ARTICLE; BILE DUCT ATRESIA; BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INTESTINE FUNCTION; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SHORT BOWEL SYNDROME;

FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; PREDNISOLONE; RETROSPECTIVE STUDIES; SHORT BOWEL SYNDROME; STATISTICS, NONPARAMETRIC; TACROLIMUS;

EID: 33746921180     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00504.x     Document Type: Article

References (17)

1. KELLY DA. Liver complications of pediatric parenteral nutrition - epidemiology. Nutrition 1998: 14: 153-157.
2. HORSLEN SP, SUDAN DL, IYER KR, et al. Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg 2002: 235: 435-439.
3. PATEL N, SMITH S, HANDA A, DARBY C. The use of oral tacrolimus in a case of short bowel syndrome. Transplant Int 2004: 17: 44-45.
4. HUBSCHER SG. Histological findings in liver allograft rejection - new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 1991: 18: 377-383.
5. THERVET E, ANGLICHEAU D, KING B, et al. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation 2003: 76: 1233-1235.
6. PELISSIER-DELOUR L, MENTION K, MICHAUD L, BONNEVALLE M, TURK D, GOTTRAND F. Favorable long-term outcome after isolated liver transplantation in a child with short bowel syndrome. J Pediatr Gastroenterol Nutr 2004: 38: 360.
7. SCHUBERT M, VENKATARAMANAN R, HOLT DW, et al. Pharmacokinetics of tacrolimus and sirolimus in pediatric transplant patients. Am J Transplant 2004: 4: 767-773.
8. NOVELLI M, MUIESAN P, MIELI-VERGANI G, DHAWAN A, RELA M, HEATON ND. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. Transplant Int 1999: 12: 463-465.
9. LAMPEN A, CHRISTIAN U, GUENGERICH FP, et al. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions and interindividual variability. Drug Metab Dispos 1995: 23: 1315-1324.
10. MOLLER A, IWASAKI K, KAWAMURA A, et al. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects. Drug Metab Dispos 1999: 27: 633-636.
11. TAMURA S, TOKUNAGA Y, IBUKI R, AMIDON GL, SEZAKI H, YAMASHITA S. The site-specific transport and metabolism of tacrolimus in rat small intestine. J Pharmacol Exp Ther 2003: 306: 310-316.
12. SHIMOMURA M, MASUDA S, SAITO H, et al. Roles of jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. J Surg Res 2002: 103: 215-222.
13. SANO N, NIO M, ISHII T, et al. Oral FK 506 blood levels are elevated in pig short bowel model: further investigations with co-administration of an intestinal CYP3A4 inhibitor. Transplant Proc 2002: 34: 1050-1051.
14. HALL BM, DORSCH S, ROSER B. The cellular basis of allograft rejection in vivo I. The cellular requirements for first-set rejection of heart grafts. J Exp Med 1978: 148: 878-889.
15. BUTCHER EC, PICKER LJ. Lymphocyte homing and homeostasis. Science 1996: 272: 60-66.
16. GRANT AJ, LALOR PF, HUBSCHER SG, BRISKIN M, ADAMS DH. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology 2001: 33: 1065-1072.
17. YANG H, FAN Y, FINALY R, TEITELBAUM DH. Alteration of intestinal intraepithelial lymphocytes after massive small bowel resection. J Surg Res 2003: 110: 276-286.